 |
For 2009, BioEquity Europe celebrates its 10th year of service by returning to Munich, site of the foundation meeting in 2000.
The past decade has witnessed the rise of bellwether leadership for Europe’s biotech industry, mounting capital inflows and an expanding product pipeline. Through it all, BioEquity Europe's mission has remained steady: To stimulate a pan-European discussion about the requirements for creating and financing European life science companies with global impact and investor appeal.
This focus has made BioEquity Europe the magnet for “Maximum Financial Networking” between biotech and pharma, public and private investors, and the investment banking community.
In Munich, BioEquity Europe 2009 will herald the achievements of the past 10 years, and showcase the biotech stories that will carry Europe's best science and technology into the next 10 years.
|
|
